Cardiotoxicity Resources

VIEW:
Select Grid View
Select Grid View
Open Filters
Hide Filter PanesHide Filter Pane

VIEW:
Select Grid View
Select Grid View

Filter By:
refresh filtersRESET FILTERS

  • WEBINAR RECORDINGS
    Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based Chemotherapy
    Publish Date June 12, 2025
    Publish Date ANTHRACYCLINES, CARDIOTOXICITY, HEART FAILURE; VENTRICULAR DYSFUNCTION, IMAGING
  • IC-OS Heart
    #N/AMEMBER PUBLICATION
    Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
    Publish Date March 28, 2024
    Publish Date CARDIOTOXICITY
  • IC-OS Heart
    EXPERT CONSENSUS
    Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
    Publish Date March 28, 2024
    Publish Date CARDIOTOXICITY
  • IC-OS Heart
    EXPERT CONSENSUS
    An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy
    Publish Date March 28, 2024
    Publish Date CARDIOTOXICITY
  • IC-OS Heart
    RESOURCES
    Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio- Oncology Society
    Publish Date March 28, 2024
    Publish Date CARDIOTOXICITY, HEART FAILURE
  • End of List

Get Certified

See All Certifications
A white doctor and a black doctor discuss the test results

Cardio-Oncology Knowledge

Go To Certification
A map of the world
Chapters

North America

Europe

Asia + Oceania

South America

Africa